| Total (N = 26) | Pediatrics (N = 5) | Organ transplantation (N = 6) | Oncology (N = 7) | Critical care (N = 8) |
---|---|---|---|---|---|
Mean ± SD (Range) | Mean ± SD (Range) | Mean ± SD (Range) | Mean ± SD (Range) | Mean ± SD (Range) | |
Patients per day (n) | 104.0 ± 89.4 (3.0-316.9) | 108.4 ± 16.6 (86.4–128.0) | 36.2 ± 28.4 (3.0–80.0) | 251.3 ± 69.6 (156.0-316.9) | 59.9 ± 32.7 (16.0–99.0) |
Total time for clinical pharmacy operation (hr) | 16.6 ± 12.5 (0.5–48.0) | 23.3 ± 7.3 (12.0-32.5) | 6.5 ± 5.2 (0.5–15.4) | 19.8 ± 12.8 (8.0–42.0) | 17.7 ± 14.7 (4.0–48.0) |
Clinical pharmacist manpower allocated to actual practice (FTE) | 2.1 ± 1.6 (0.1-6.0) | 2.8 ± 0.9 (1.5–4.1) | 0.8 ± 0.6 (0.1–1.9) | 2.5 ± 1.8 (1.0-5.3) | 2.2 ± 1.8 (0.5–60.0) |
 | n (%) | n (%) | n (%) | n (%) | n (%) |
Prescription review | |||||
All patients, all medications | 16 (62%) | 5 (100%) | 3 (50%) | 2 (29%) | 6 (75%) |
Some of priority patients, all medications | 7 (27%) | 0 (0%) | 3 (50%) | 2 (29%) | 2 (25%) |
Some of priority patients, specific medications | 3 (12%) | 0 (0%) | 0 (0%) | 3 (43%) | 0 (0%) |
Consultation | |||||
Therapeutic drug monitoring | |||||
Clinical pharmacists in multidisciplinary team | 15 (58%) | 4 (80%) | 2 (33%) | 2 (29%) | 7 (88%) |
General clinical pharmacists | 7 (27%) | 0 (0%) | 3 (50%) | 4 (57%) | 0 (0%) |
None | 4 (15%) | 1 (20%) | 1 (17%) | 1 (14%) | 1 (13%) |
Nutrition support | |||||
Clinical pharmacists in multidisciplinary team | 14 (54%) | 5 (100%) | 0 (0%) | 2 (29%) | 7 (88%) |
General clinical pharmacists | 12 (46%) | 0 (0%) | 6 (100%) | 5 (71%) | 1 (13%) |
Medication education | |||||
Patient education for specific medication | |||||
Clinical pharmacists in multidisciplinary team | 16 (62%) | 4 (80%) | 6 (100%) | 6 (86%) | 0 (0%) |
General clinical pharmacists | 5 (19%) | 0 (0%) | 0 (0%) | 1 (14%) | 4 (50%) |
None | 5 (19%) | 1 (20%) | 0 (0%) | 0 (0%) | 4 (50%) |
Patient education for discharge medication | |||||
Clinical pharmacists in multidisciplinary team | 11 (42%) | 4 (80%) | 4 (67%) | 3 (43%) | 0 (0%) |
General clinical pharmacists | 8 (31%) | 1 (20%) | 2 (33%) | 3 (43%) | 2 (25%) |
None | 7 (27%) | 0 (0%) | 0 (0%) | 1 (14%) | 6 (75%) |